We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Htetf (MM) | NASDAQ:HTRN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.84 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of
earliest event reported)
March 4, 2010
HEALTHTRONICS, INC.
Georgia | 000-30406 | 58-2210668 | ||
|
|
|
||
(State or Other Jurisdiction
of Incorporation) |
(Commission File Number) |
(I.R.S. Employer
Identification No.) |
9825 Spectrum Drive,
Building 3
Austin, Texas 78717
(512) 328-2892
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On March 4, 2010, HealthTronics, Inc. (the Company) issued a press release announcing its financial results for the quarter and year ended December 31, 2009. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8 K.
Item 7.01. Regulation FD Disclosure.
On March 4, 2010, management of the Company held an earnings call to discuss the Companys financial
results for the quarter and year ended December 31, 2009, the transcript of which is attached to this Current
Report on Form 8-K as Exhibit 99.2. The Company is furnishing this transcript pursuant to the Securities and
Exchange Commissions Regulation FD. This information is furnished pursuant to Item 7.01 of Form 8-K and shall
not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that Section, unless the Company specifically incorporates it by reference in a
document filed under the Securities Act of 1933 or the Securities Exchange Act of 1934. By filing this report on
Form 8-K and furnishing this information, the Company makes no admission as to the materiality of any information
in this report that the Company chooses to disclose solely because of Regulation FD.
The Company undertakes no duty or obligation to publicly update or revise the information contained in
this report, although the Company may do so from time to time as the Companys management believes is warranted.
Any such updating may be made through the filing of other reports or documents with the SEC, through press
releases or through other public disclosure.
Certain expectations and projections regarding the Companys future performance referenced in this
transcript are forward-looking statements. These expectations and projections are based on currently available
competitive, financial, and economic data, along with the Companys operating plans, and are subject to future
events and uncertainties. Among the events and uncertainties that could adversely affect future periods are: the
risk that the operations of Endocare, Inc. will not be successfully integrated; the risk that the Companys
expected cost savings and other synergies from the acquisition of Endocare may not be fully realized, realized at
all or take longer to realize than anticipated; the Companys inability to establish or maintain relationships
with physicians and hospitals; the impact of healthcare regulatory developments and changes; the inability of
healthcare providers to obtain reimbursement for use of the Companys current or future products or services;
competition or technological change that impacts the market for the Companys products; difficulty in managing
the Companys growth; and other factors described in the Companys periodic reports filed with the SEC. In
addition to the above cautionary statements, all forward-looking statements contained herein should be read in
conjunction with the Companys SEC filings, including the risk factors described therein, and other public
announcements.
Item 9.01 Financial Statements and Exhibits.
(d) | Exhibits. |
Exhibit Number |
Description |
|
99.1 | Press release dated March 4, 2010. | |
99.2 | Transcript. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTHTRONICS, INC.
|
||||||||
Date: March 8, 2010 | By: | /s/ Richard A. Rusk | ||||||
|
||||||||
Name:
Title: |
Richard A. Rusk Chief Financial Officer and Vice President |
|||||||
EXHIBIT INDEX
Exhibit Number |
Description |
|
99.1 | Press release dated March 4, 2010. | |
99.2 | Transcript. |
1 Year Htetf (MM) Chart |
1 Month Htetf (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions